Published guidance, NICE advice and quality standards | Guidance

Showing 571 to 580 of 797

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Cobimetinib in combination with vemurafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma	TA414	26 October 2016	26 October 2016
Necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancer	TA411	28 September 2016	28 September 2016
Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastases	TA412	28 September 2016	28 September 2016
Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer	TA406	28 September 2016	28 September 2016
Secukinumab for active ankylosing spondylitis after treatment with non-steroidal anti-inflammatory drugs or TNF-alpha inhibitors	TA407	28 September 2016	28 September 2016
Pegaspargase for treating acute lymphoblastic leukaemia	TA408	28 September 2016	28 September 2016
Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion	TA409	28 September 2016	28 September 2016
Talimogene laherparepvec for treating unresectable metastatic melanoma	TA410	28 September 2016	28 September 2016
Bosutinib for previously treated chronic myeloid leukaemia	TA401	24 August 2016	24 August 2016
Pemetrexed maintenance treatment for non-squamous non-small-cell lung cancer after pemetrexed and cisplatin	TA402	24 August 2016	24 August 2016